Your browser doesn't support javascript.
loading
Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1+ CD8+ and CD8+ T cells as predictive of response to neoadjuvant chemotherapy in breast cancer.
Liang, Hongling; Li, Hongsheng; Xie, Zhi; Jin, Tianen; Chen, Yu; Lv, Zhiyi; Tan, Xiaojun; Li, Jia; Han, Guodong; He, Weixing; Qiu, Ni; Jiang, Ming; Zhou, Jie; Xia, Haoming; Zhan, Yongtao; Cui, Lulu; Guo, Weiling; Huang, Jianqing; Zhang, Xuchao; Wu, Yi-Long.
Afiliación
  • Liang H; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Li H; Department of Breast Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Xie Z; Department of Breast Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Jin T; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Chen Y; Guangzhou DaAn Clinical Laboratory Center, Guangzhou, China.
  • Lv Z; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Tan X; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Li J; Department of Pathology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Han G; Graduate School of Arts and Science, Columbia University in the City of New York, New York, New York, USA.
  • He W; Department of Breast Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Qiu N; Department of Breast Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Jiang M; Department of Breast Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Zhou J; Department of Breast Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Xia H; Department of Breast Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Zhan Y; Department of Breast Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Cui L; Department of Breast Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Guo W; Department of Breast Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Huang J; Department of Breast Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Zhang X; Department of Breast Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Wu YL; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Thorac Cancer ; 11(10): 2941-2954, 2020 10.
Article en En | MEDLINE | ID: mdl-32894006

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Linfocitos Infiltrantes de Tumor / Linfocitos T CD8-positivos / Terapia Neoadyuvante Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Thorac Cancer Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Singapur

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Linfocitos Infiltrantes de Tumor / Linfocitos T CD8-positivos / Terapia Neoadyuvante Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Thorac Cancer Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Singapur